La Jolla Institute for Immunology
About La Jolla Institute for Immunology
Since its inception 30 years ago, La Jolla Institute has solely dedicated itself to understanding the far-reaching power of the immune system because we believe that no other biomedical discipline has greater implications for human health than immunology.
4 articles about La Jolla Institute for Immunology
-
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
4/19/2024
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
-
The arrangement provides the opportunity for LJI faculty and postdocs to make a more immediate impact on drug development while offering a different perspective to KKNA.
-
La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform
12/9/2019
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
-
Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies
9/4/2018
​Turnstone Obtaining License to Neoantigen Identification Methodology Developed by the La Jolla Institute.